How Does GHK-Cu Compare to Other Dermal-Repair Research Peptides?
These four compounds are all studied in dermal-research contexts but work through distinct mechanisms. GHK-Cu's copper-complex structure drives broad gene-expression modulation, fibroblast activation, and antioxidant pathway activity. Matrixyl (pal-KTTKS) is a pentapeptide that signals collagen I/III biosynthesis more narrowly. Argireline (acetyl hexapeptide-3) works differently still, inhibiting SNAP-25/SNARE complex formation to relax muscle contraction. EGF is a full growth-factor protein (53 amino acids) that binds the EGFR receptor to drive keratinocyte proliferation and wound closure.
GHK-Cu's research profile is also the most extensively documented of the four by publication volume — the Pickart lab's genomic-scale analysis (Biotechnology, 2010) documenting modulation of over 4,000 genes is the most frequently cited data point distinguishing it from the narrower-mechanism peptides in this comparison.
REVIVE LAB UAE currently stocks GHK-Cu specifically — Matrixyl, Argireline, and EGF are not part of its catalog. This comparison reflects general dermal-research literature and is provided as research background only.
| Peptide | Type / Class | Primary Mechanism |
|---|---|---|
| GHK-Cu | Copper tripeptide | Modulates ~4,000 genes; fibroblast activation; ECM synthesis |
| Matrixyl (pal-KTTKS) | Pentapeptide | Collagen I/III biosynthesis signal |
| Argireline (acetyl hexapeptide-3) | Hexapeptide | SNAP-25 / SNARE inhibition (muscle relaxation) |
| EGF | Growth factor protein (53 aa) | EGFR receptor agonism, keratinocyte proliferation |
Purity ≥ 98.0% (HPLC) · COD, card or Binance Pay (5% off) Order GHK-Cu UAE — Live Stock & Pricing